Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up (Q35090649)

6 August 2017

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up (English)

1 reference

6 August 2017

1 reference

0 references

1 reference

6

Raymond T Chung

1 reference

6 August 2017

Kathleen E Corey

1

1 reference

6 August 2017

Erin Kane

2

1 reference

6 August 2017

Craig Munroe

3

1 reference

6 August 2017

Lydia L Barlow

4

1 reference

6 August 2017

Hui Zheng

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

6 August 2017

1 reference

6 August 2017

50

1 reference

6 August 2017

1030-1037

1 reference

6 August 2017

4

1 reference

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Interaction of hepatitis C virus proteins with host cell membranes and lipids

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

A receptor-mediated pathway for cholesterol homeostasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.23219

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.23219

Serum cholesterol and chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4330996

Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787818

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.23219

1 reference

6 August 2017

1 reference

6 August 2017

1 reference